Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation

Abstract

The recurrence and survival outcomes after LDLT and DDLT were comparable on an intent-to-treat analysis. Shorter waiting time preventing dropouts is an additional advantage with LDLT. LDLT for HCC patients beyond validated criteria should be proposed with caution.